Invivyd, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO William E. Duke Jr., with a market cap of $503.4M.
Common questions about Invivyd, Inc.
Invivyd, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $18.2M.
Invivyd, Inc. has approximately 95 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.